METABOLIC DISORDER-ASSOCIATED TARGET GENE IRNA COMPOSITIONS AND METHODS OF USE THEREOF

PDE5A DESTABILIZING DOMAINS

COMPOSITIONS AND METHODS FOR TUNABLE REGULATION OF TRANSCRIPTION

MATERIALS AND METHODS FOR DETECTING AND TREATING AUTOIMMUNE MOVEMENT DISORDERS

PDE5A destabilizing domains

Treatment of synucleinopathies

METHODS FOR MODULATING CYCLIC NUCLEOTIDE-MEDIATED SIGNALING IN CARDIAC MYOCYTES AND COMPOSITIONS

Methods for modulating cyclic nucleotide-mediated signaling in cardiac myocytes and compositions

Neuronal pain pathway

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

Neuronal pain pathway

Phosphodiesterase 4D7 as marker for malignant, hormone-sensitive prostate cancer

Phosphodiesterase 4D7 as prostate cancer marker

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor

Neuronal pain pathway

Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor